We are live on
!
Find out more
AG
Artal Group Portfolio holdings
AUM
$1.01B
1-Year Est. Return
29.84%
This Fund
S&P 500
This Quarter
Est. Return
-3.9%
1 Year Est. Return
+29.84%
3 Year Est. Return
+144%
5 Year Est. Return
+76.57%
10 Year Est. Return
+1,417.6%
AUM
$2.47B
AUM Growth
-$289M
(-10%)
Cap. Flow
-$262M
Cap. Flow
% of AUM
-10.6%
Top 10 Holdings %
Top 10 Hldgs %
61.17%
Holding
110
New
16
Increased
30
Reduced
10
Closed
25
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$15.8M |
| 2 |
AUXL
AUXILIUM PHARAMCEUTICALS INC
AUXL
|
+$14.7M |
| 3 |
Incyte
INCY
|
+$14.3M |
| 4 |
Ionis Pharmaceuticals
IONS
|
+$11.2M |
| 5 |
Terex
TEX
|
+$6.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FURX
FURIEX PHARMACEUTICALS INC COM STK (DE)
FURX
|
+$78.4M |
| 2 |
Amgen
AMGN
|
+$17.4M |
| 3 |
Dollar General
DG
|
+$13.9M |
| 4 |
MJN
Mead Johnson Nutrition Company
MJN
|
+$12.5M |
| 5 |
BRFS
BRF SA
BRFS
|
+$10.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 25.19% |
| 2 | Healthcare | 24.42% |
| 3 | Financials | 1.12% |
| 4 | Industrials | 0.54% |
| 5 | Technology | 0.15% |
Similar funds
BCM
GA
EPAM
WA
CT
AH
PIM
MAM
Artal Group's Q2 2014 Portfolio in Review
As of Q2 2014, Artal Group held 110 positions worth $2.47B, down 10% from $2.76B the previous quarter. Its ten largest holdings account for 61% of the portfolio.
Artal Group withdrew a net $262M in Q2 2014, closing 25 positions and reducing 10 holdings. Its most notable exit was FURIEX PHARMACEUTICALS INC COM STK (DE), an estimated $78.4M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Artal Group opened a new position in Amazon worth $16.2M.
- Artal Group's largest Q2 2014 buy was Amazon: 1,000,000 shares worth $16.2M.
- Artal Group added most to AUXILIUM PHARAMCEUTICALS INC in Q2 2014, an estimated $14.7M increase.
- Artal Group's biggest Q2 2014 reduction was Ralph Lauren, cutting an estimated $3.85M.
- Artal Group fully exited FURIEX PHARMACEUTICALS INC COM STK (DE) in Q2 2014, selling an estimated $78.4M.
- Artal Group's ten largest holdings make up 61% of its $2.47B portfolio in Q2 2014.
- Artal Group opened 16 new positions and closed 25 in Q2 2014.
- Artal Group's portfolio value fell 10% quarter-over-quarter to $2.47B.
Based on Artal Group's 13F filing for Q2 2014, filed 14 Aug 2014.